Cargando…
The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries
BACKGROUND: Despite the increase in the number of clinical trials in low and middle income countries (LMICs), there has been little serious discussion of whether First in Human (FIH; phase 0 and phase 1) clinical trials should be conducted in LMICs, and if so, under what conditions. Based on our own...
Autores principales: | Kapiriri, Lydia, Lavery, James V, Singer, Peter A, Mshinda, Hassan, Babiuk, Lorne, Daar, Abdallah S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339411/ https://www.ncbi.nlm.nih.gov/pubmed/22008649 http://dx.doi.org/10.1186/1471-2458-11-811 |
Ejemplares similares
-
Authorship ethics in global health research partnerships between researchers from low or middle income countries and high income countries
por: Smith, Elise, et al.
Publicado: (2014) -
Early life opportunities for prevention of diabetes in low and middle income countries
por: Hanson, Mark A, et al.
Publicado: (2012) -
Human-animal chimeras for vaccine development: an endangered species or opportunity for the developing world?
por: Bhan, Anant, et al.
Publicado: (2010) -
Optimizing patient-centeredness in the transitions of healthcare systems in low- and middle-income countries
por: Mahendradhata, Yodi, et al.
Publicado: (2014) -
Rethinking the service delivery system of psychological interventions in low and middle income countries
por: Murray, L. K., et al.
Publicado: (2016)